Sanjivani Paranteral has informed that at the meeting of the Board of Directors of the Company held on Thursday, March 24, 2022, the following items were noted, considered and approved: Appointment of Monika Amit Singhania (DIN : 07950196) as an Additional Independent Director on the Board of the Company with effect from March 24, 2022 and Appointment of Srivardhan Ashwani Khemka (DIN: 089421 06) as an Additional Director (Non-Executive Promoter) on the Board of the Company with effect from March 24, 2022. The above appointment of Monika Amit Singhania and Srivardhan Ashwani Khemka is subject to approval by shareholders of the Company. Information as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is given in the enclosed Annexure.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: